Biotech

All Articles

Novartis pens $150M beforehand bispecifics cope with Dren Bio

.Novartis has actually possessed some bad luck with bispecific antitoxins in the past, but evaluatin...

AstraZeneca vegetations an EGFR tree with Pinetree deal worth $45M

.Pinetree Therapies will definitely assist AstraZeneca vegetation some trees in its pipeline along w...

GRO rounds up $60M series B to take gout therapy into facility

.GRO Biosciences has finished the week with an added $60.3 million in the bank, which the healthy pr...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds CEO

.Welcome to this week's Chutes &amp Ladders, our summary of significant management hirings, firings ...